Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates

Journal of Infection and Chemotherapy

Volumn 7, Issue 3, 2001, Pages 142-147

  Tabe, Y ^a   Nakamura, A ^b   Igari, J ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Agar selection; Glycopeptide; Multiresistant Staphylococcus haemolyticus; Pulsed field gel electrophoresis (PFGE); Teicoplanin; Vancomycin

Indexed keywords

AGAR; GLYCOPEPTIDE; METICILLIN; OXACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM COLONY; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; HOSPITAL INFECTION; HUMAN; MEDICAL STAFF; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 0034767261     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560100026     Document Type: Article

References (33)

1. An epidemiological study of blood culture isolates of coagulase-negative Staphylococci demonstrating hospital-acquired infection
2. Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: A problem of increasing importance
3. Emergence of teicoplanin-resistant coagulase-negative staphylococci
4. Predominant pathogens in hospital infections
5. Changing patterns of bacterial nosocomial infections: A 9-year study in a general hospital
6. Laboratory, clinical, and epidemiological aspects of coagulase-negative Staphylococci
7. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay
8. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus
9. Gram-positive infections in neutropenic patients: Glycopeptide antibiotics choice
10. Correspondence: Vancomycin-resistant staphylococcus
11. Gram-positive vancomycin-resistant clinical isolates
12. Emergence of vancomycin resistance in coagulase-negative Staphylococci
13. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus
14. Breakthough nosocomial bacteraemia due to teicoplanin-resistant Staphylococcus haemolyticus in five patients with acute leukemia
15. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection
16. Bacteremia due to teicoplaninresistant and vancomycin-susceptible Staphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin
17. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp
18. Nosocomial infection by Staphylococcus haemolyticus and typing methods for epidemiological study
19. Anti-Staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: The significance of methicillin resistance
20. Antimicrobial susceptibility of coagulase-negative Staphylococci and characterization of isolates with reduced susceptibility to glycopeptides
21. Molecular characterization of epidemic multi-resistant Staphylococcus haemolyticus isolates
22. Performance standards for antimicrobial susceptibility testing
23. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
24. Increased oxacillin activity associated with glycopeptides in coagulase-negative Staphylococci
25. Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphyloccocci
26. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
27. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients
28. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus
29. Coagulasenegative staphylococcal bacteraemia treated with teicoplanin
30. Clinical and microbiologic aspects of Staphylococcus haemolyticus infections
31. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus in the bloodstream
32. Comparison of phage typing and DNA fingerprinting by polymerase chain reaction for discrimination of methicillin-resistant Staphylococcus aureus strains
33. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus